Background: This study investigated the value of postoperative stimulated thyroglobulin (Tg)
combined with neck ultrasonography for the prediction of the posttherapy whole-body …

Purpose To compare disease-specific survival and recurrence-free survival (RFS) after
successful 131 I ablation in patients with differentiated thyroid carcinoma (DTC) between …

Background A diagnostic I-131 (Dx) scan is used to detect a thyroid remnant or metastases
before treatment of differentiated thyroid cancer (DTC) with I-131. The aim of this study is to …

Radioiodine imaging in initial perioperative settings, after the total thyroidectomy, includes
pre-treatment and post-treatment radioiodine imaging. While the benefit of post-treatment …

A growing body of evidence is challenging the indiscriminate use of postoperative
radioiodine for remnant ablation (RRA) in low-risk (LR) differentiated thyroid cancer patients …

Remnant ablation by radioiodine is generally not recommended in patients presenting uni-
or multifocal cancer< 1 cm, in the absence of other higher risk features. We retrospectively …

Objectives Radioiodine can be applied for remnant ablation in low and low to intermediate-
risk patients with differentiated thyroid cancer (DTC). A controversy still exists about the …

AIM: Recombinant human thyroid-stimulating hormone (rhTSH) has been approved in
Europe as a preparation tool for radioiodine ablation of post-surgical thyroid remnants in …

Background: Most patients with well-differentiated thyroid cancer (WDTC) are first treated by
total thyroidectomy followed by remnant ablation (RA) with 131I. There are less data …

Initial treatment for differentiated thyroid carcinoma (DTC) often consists of surgery and the
administration of radioiodine. In this context, post-treatment Whole-Body Scans (ptWBS) are …